Janssen Search
Search results
David Gordon, M.B., Ch.B.
DAVID GORDON, M.B., CH.B. Global Head of Clinical Development Immunology David Gordon, M.B., Ch.B., is Global Head of Clinical Development for the Immunology Therapeutic Area (TA) at Janssen Research & Development, LLC. In this role, he is responsible ...
Partner With Our Research & Development Team
Partner With Janssen Research & Development Collaboration is in our DNA. We know where it has taken us. We know it can take us further. With a rally cry as simple as "&." Collaborations A key element of our Janssen Research & ...
Careers in Research & Development
Janssen Research & Development: Careers Our employees start each day with a new opportunity to transform healthcare and improve the quality of life for people in all corners of the world. We have made this our mission and our passion, and if you share ...
Oncology Development Capabilities
Late Development: Delivering on Discovery’s Potential “When we see something special in oncology research, we will go the ends of the earth to get it done.” Craig Tendler, M.D. Vice President, Late Development and Global Medical Affairs Our world-class ...
Gopi Shankar, M.B.A., Ph.D.
GOPI SHANKAR, M.B.A., PH.D. VICE PRESIDENT HEAD BIOLOGICS DEVELOPMENT SCIENCES Gopi Shankar, M.S., Ph.D., MBA, FAAPS, is Vice President and Head of Biologics Development Sciences (BDS) within Janssen BioTherapeutics (JBIO), Janssen Research & ...
Janssen Enters into Agreement with Sanofi to Advance Potential First-In-Class Vaccine Program
Oct 03, 2023 United States Vaccine candidate is being evaluated in Phase 3 study for the prevention of invasive E. coli disease (IED) which affects nearly 10 million adults annually 1 TITUSVILLE, N.J., October 3, 2023 – Janssen Pharmaceuticals, Inc. ...
The New Science of Cancer Interception
Thwarting Deadly Diseases Before They Start: The New Science of Cancer Interception Imagine if your doctor could detect cancer before it began growing in your body, then give you medicine to prevent it from taking hold. This researcher explains how she ...
Better Medicines, Healthier Communities: Improving Health Equity in Cancer Clinical Trials
Better Medicines, Healthier Communities: Improving Health Equity in Cancer Clinical Trials The Johnson & Johnson Our Race to Health Equity initiative aims to help increase access to health care, including clinical trials, for underserved and ...
Charles Drake, M.D., Ph.D.
CHARLES DRAKE, M.D., PH.D. Vice President IMMUNO-ONCOLOGY Charles (Chuck) Drake, M.D., Ph.D. is Vice President, Immuno-oncology (I-O) at Janssen Research & Development, LLC. In this position, he is responsible for leading the I-O team in their efforts ...
Global Reach
Article Type: Infectious Diseases & Vaccines Global Reach We seek opportunities to combine our scientific capabilities with world-class innovation from government, industry and academia to speed up the development of solutions that will combat the ...